Terms: = Pancreatic cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun AND Treatment
115 results:
1. Inhibition of ATM promotes PD-L1 expression by activating JNK/c-jun/TNF-α signaling axis in triple-negative breast cancer.
Liu C; Qian X; Yu C; Xia X; Li J; Li Y; Xie Y; Gao G; Song Y; Zhang M; Xue H; Wang X; Sun H; Liu J; Deng W; Guo X
Cancer Lett; 2024 Apr; 586():216642. PubMed ID: 38278470
[TBL] [Abstract] [Full Text] [Related]
2. Hepatic prohibitin 1 and methionine adenosyltransferase α1 defend against primary and secondary liver cancer metastasis.
Fan W; Cao D; Yang B; Wang J; Li X; Kitka D; Li TWH; You S; Shiao S; Gangi A; Posadas E; Di Vizio D; Tomasi ML; Seki E; Mato JM; Yang H; Lu SC
J Hepatol; 2024 Mar; 80(3):443-453. PubMed ID: 38086446
[TBL] [Abstract] [Full Text] [Related]
3. Current status of Complementary and Alternative Medicine Interventions in the Management of pancreatic cancer - An Overview.
Tarasiuk A; Mirocha G; Fichna J
Curr Treat Options Oncol; 2023 Dec; 24(12):1852-1869. PubMed ID: 38079061
[TBL] [Abstract] [Full Text] [Related]
4. TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma.
Zhou Y; Jin J; Ji Y; Zhang J; Fu N; Chen M; Wang J; Qin K; Jiang Y; Cheng D; Deng X; Shen B
J Transl Med; 2023 Dec; 21(1):872. PubMed ID: 38037073
[TBL] [Abstract] [Full Text] [Related]
5. Metformin reduces hepatocarcinogenesis by inducing downregulation of Cyp26a1 and CD8
He W; Wang X; Chen M; Li C; Chen W; Pan L; Cui Y; Yu Z; Wu G; Yang Y; Xu M; Dong Z; Ma K; Wang J; He Z
Clin Transl Med; 2023 Nov; 13(11):e1465. PubMed ID: 37997519
[TBL] [Abstract] [Full Text] [Related]
6. Immunization with a multi-antigen targeted DNA vaccine eliminates chemoresistant pancreatic cancer by disrupting tumor-stromal cell crosstalk.
Qin H; Chen J; Bouchekioua-Bouzaghou K; Meng YM; Griera JB; Jiang X; Kong X; Wang M; Xu Q; Wong PP
J Transl Med; 2023 Oct; 21(1):702. PubMed ID: 37814317
[TBL] [Abstract] [Full Text] [Related]
7. Exploring dual effects of dinutuximab beta on cell death and proliferation of insulinoma.
Karatug Kacar A
Chem Biol Drug Des; 2024 Jan; 103(1):e14368. PubMed ID: 37802653
[TBL] [Abstract] [Full Text] [Related]
8. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/Yap1/c-jun axis.
Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J
J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164
[TBL] [Abstract] [Full Text] [Related]
9. The transcription factor jun is a major regulator of quiescent pancreatic stellate cell maintenance.
Lin H; Ye Z; Xu R; Li XE; Sun B
Gene; 2023 Jan; 851():147000. PubMed ID: 36283605
[TBL] [Abstract] [Full Text] [Related]
10. Neurotrophin3 promotes hepatocellular carcinoma apoptosis through the JNK and P38 MAPK pathways.
Yang Z; Zhang H; Yin M; Cheng Z; Jiang P; Feng M; Liao B; Liu Z
Int J Biol Sci; 2022; 18(15):5963-5977. PubMed ID: 36263167
[TBL] [Abstract] [Full Text] [Related]
11. PBRM1 presents a potential prognostic marker and therapeutic target in duodenal papillary carcinoma.
He X; Xu J; Niu N; Xu G; Zhu H; Liu Z; Mou Y; Qian Z; Wang H; Hu J; Ma T; Ma J; Tao H
Clin Transl Med; 2022 Oct; 12(10):e1062. PubMed ID: 36178086
[TBL] [Abstract] [Full Text] [Related]
12. treatment with b-ap15 to Inhibit UCHL5 and USP14 Deubiquitinating Activity and Enhance p27 and Cyclin E1 for Tumors with
Jiang ZY; Hong J; Zhang JH; Wang XF; Ma YS; Xiong ZX; Sun HR; Cheng C; Xie BZ; Liu JB; Ouyang YG; Fu D
Technol Cancer Res Treat; 2022; 21():15330338221119745. PubMed ID: 35971329
[No Abstract] [Full Text] [Related]
13. Novel protein kinase inhibitor TT-00420 inhibits gallbladder cancer by inhibiting JNK/jun-mediated signaling pathway.
Miao H; Geng Y; Li Y; Tang S; Feng F; Li W; Li Y; Liu L; Zhang R; Qiu S; Wu Y; Wang Z; Wang Z; Shao Z; Liu K; Zou L; Yang M; Zhao Y; Chen C; Li Z; Zhang D; Peng P; Qiang X; Wu F; He Y; Chen L; Xiang D; Jiang X; Li M; Liu Y; Liu Y
Cell Oncol (Dordr); 2022 Aug; 45(4):689-708. PubMed ID: 35870050
[TBL] [Abstract] [Full Text] [Related]
14. Gene Differential Expression and Interaction Networks Illustrate the Biomarkers and Molecular Biological Mechanisms of Unsaponifiable Matter in Kanglaite Injection for pancreatic Ductal Adenocarcinoma.
Xu B; Dan W; Zhang X; Wang H; Cao L; Li S; Li J
Biomed Res Int; 2022; 2022():6229462. PubMed ID: 35707377
[TBL] [Abstract] [Full Text] [Related]
15. ITGBL1 transcriptionally inhibited by JDP2 promotes the development of pancreatic cancer through the TGF-beta/Smad pathway.
Du T; Zhang K; Zhang Z; Guo A; Yu G; Xu Y
Braz J Med Biol Res; 2022; 55():e11989. PubMed ID: 35584452
[TBL] [Abstract] [Full Text] [Related]
16. Mechanical Stress Signaling in pancreatic cancer Cells Triggers p38 MAPK- and JNK-Dependent Cytoskeleton Remodeling and Promotes Cell Migration via Rac1/cdc42/Myosin II.
Kalli M; Li R; Mills GB; Stylianopoulos T; Zervantonakis IK
Mol Cancer Res; 2022 Mar; 20(3):485-497. PubMed ID: 34782370
[TBL] [Abstract] [Full Text] [Related]
17. Integrating Network Pharmacology and Experimental Verification to Explore the Mechanism of Effect of Zuojin Pills in pancreatic cancer treatment.
Wang K; Miao X; Kong F; Huang S; Mo J; Jin C; Zheng Y
Drug Des Devel Ther; 2021; 15():3749-3764. PubMed ID: 34511884
[TBL] [Abstract] [Full Text] [Related]
18. Adaptive planning based on single beam optimization in passive scattering carbon ion radiotherapy for patients with pancreatic cancer.
Li Y; Kubota Y; Okamoto M; Shiba S; Okazaki S; Matsui T; Tashiro M; Nakano T; Ohno T
Radiat Oncol; 2021 Jun; 16(1):111. PubMed ID: 34147099
[TBL] [Abstract] [Full Text] [Related]
19. treatment of 13-cis retinoic acid and 1,25-dihydroxyvitamin D3 inhibits TNF-alpha-mediated expression of MMP-9 protein and cell invasion through the suppression of JNK pathway and microRNA 221 in human pancreatic adenocarcinoma cancer cells.
Cheng YH; Chiang EI; Syu JN; Chao CY; Lin HY; Lin CC; Yang MD; Tsai SY; Tang FY
PLoS One; 2021; 16(3):e0247550. PubMed ID: 33730072
[TBL] [Abstract] [Full Text] [Related]
20. Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation.
Li L; Bao J; Wang H; Lei JH; Peng C; Zeng J; Hao W; Zhang X; Xu X; Yu C; Deng CX; Chen Q
Theranostics; 2021; 11(4):1672-1689. PubMed ID: 33408774
[No Abstract] [Full Text] [Related]
[Next]